Skip to main content
SpringerLink
Log in

Newly Described Entities in Renal Tumor Pathology

  • Chapter
  • First Online:
Genitourinary Pathology

  • 1701 Accesses

Abstract

Several new kidney tumor entities have been described since the publication of the 2004 World Health Organization (WHO) classification of renal tumors. These entities are included in the recent International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia and are described in this chapter with a description of morphology, genetics, and ancillary diagnostic information relevant to distinguishing them from established diagnostic categories. Prognostic information, where available, is also provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amin MB, editor. Diagnostic pathology. 1st ed. Manitoba: Amirsys; 2010.

    Google Scholar 

  2. Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30(2):141–53.

    Article  PubMed  Google Scholar 

  3. Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32(8):1239–45.

    Article  PubMed  Google Scholar 

  4. Zhou H, Zheng S, Truong LD et al. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol 2014; 45(1):59–64.

    Google Scholar 

  5. Tickoo SK, Reuter VE. Differential diagnosis of renal tumors with papillary architecture. Adv Anal Pathol 2011;18:120–132.

    Google Scholar 

  6. Fine SW, Chen Y, Al-Ahmadie HA, Gopalan A. RVETSK. Immunohistochemical Profile of Clear Cell and Related Renal Cell Cancers, with Emphasis on CK7 and Carbonic Anhydrase-IX (CA-IX) Staining. United States and Canadian Academy of Pathology Annual Meeting; February 2012; Vancouver, BC: Modern Pathology; 2012:204A.

    Google Scholar 

  7. Kuroda N, Shiotsu T, Kawada C, Shuin T, Hes O, Michal M, et al. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol. 2011;15(4):282–5.

    Article  PubMed  Google Scholar 

  8. Rohan SM, Xiao Y, Liang Y et al. Clear- cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on von Hippel Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 2011; 24(9): 1207–20.

    Google Scholar 

  9. Michal M, Hes O, Nemcova J, Sima R, Kuroda N, Bulimbasic S, et al. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch Int J Pathol. 2009;454(1):89–99.

    Article  CAS  Google Scholar 

  10. Verine J. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009;454(4):479–80.

    Article  CAS  PubMed  Google Scholar 

  11. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol. 2002;10(4):332–8.

    CAS  PubMed  Google Scholar 

  12. Gupta R, Balzer B, Picken M, Osunkoya AO, Shet T, Alsabeh R, et al. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg Pathol. 2009;33(2):241–7.

    Article  PubMed  Google Scholar 

  13. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24(2):203–10.

    Article  CAS  PubMed  Google Scholar 

  14. Tretiakova MS, Sahoo S, Takahashi M, Turkyilmaz M, Vogelzang NJ, Lin F, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004;28(1):69–76.

    Article  PubMed  Google Scholar 

  15. Carvalho JC, Wasco MJ, Kunju LP, Thomas DG, Shah RB. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Histopathology. 2011;58(2):169–79.

    Article  PubMed  Google Scholar 

  16. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10(6):537–44.

    CAS  PubMed  Google Scholar 

  17. Wu A, Kunju L, Cheng L, Shah R. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes. Histopathology. 2008;53:533–44.

    Article  CAS  PubMed  Google Scholar 

  18. Argani P, Olgac S, Tickoo S, Goldfischer M, Moch H, Chan D, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31:1149–60.

    Article  PubMed  Google Scholar 

  19. Amin MB, MacLennan GT, Gupta R, Grignon D, Paraf F, Vieillefond A, et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009;33(3):384–92.

    Article  PubMed  Google Scholar 

  20. MacLennan GT, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology. 1997;50(5):679–84.

    Article  CAS  PubMed  Google Scholar 

  21. Osunkoya AO, Young AN, Wang W, Netto GJ, Epstein JI. Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. Am J Surg Pathol. 2009;33(7):1103–6.

    Article  PubMed  Google Scholar 

  22. Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, et al. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol. 2009;33(12):1840–9.

    Article  PubMed  Google Scholar 

  23. Alexiev BA, Drachenberg CB. Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study. Virchows Arch. 2013;462(5):575–81.

    Article  CAS  PubMed  Google Scholar 

  24. Azoulay S, Vieillefond A, Paraf F, Pasquier D, Cussenot O, Callard P, et al. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch. 2007;451(5):905–9.

    Article  PubMed  Google Scholar 

  25. Yang XJ, Zhou M, Hes O, Shen S, Li R, Lopez J, et al. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol. 2008;32(2):177–87.

    Article  PubMed  Google Scholar 

  26. Al-Hussain TO, Cheng L, Zhang S, Epstein JI. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis. Hum Pathol. 2013;44(7):1406–11.

    Article  CAS  PubMed  Google Scholar 

  27. Kuroda N, Ohe C, Mikami S, Hes O, Michal M, Brunelli M, et al. Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol. 2011;26(9):1215–8.

    CAS  PubMed  Google Scholar 

  28. Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005;29(4):443–51.

    Article  PubMed  Google Scholar 

  29. Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol. 2006;19(6):780–7.

    CAS  PubMed  Google Scholar 

  30. Pan CC, Chen YJ, Chang LC, Chang YH, Ho DM. Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology. 2009;55(2):145–53.

    Article  PubMed  Google Scholar 

  31. Kuroda N, Yamashita M, Kakehi Y, Hes O, Michal M, Lee GH. Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study. Med Mol Morphol. 2011;44(4):228–32.

    Article  CAS  PubMed  Google Scholar 

  32. Kuroda N, Tamura M, Hamaguchi N, Mikami S, Pan CC, Brunelli M, et al. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol. 2011;15(6):462–6.

    Article  PubMed  Google Scholar 

  33. Eble J, Suter G, Epstein J, Sesterhenn I, editors. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.

    Google Scholar 

  34. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005;25:363–78.

    Article  PubMed  Google Scholar 

  35. Argani P, Aulmann S, Karanjawala Z, Fraser R, Ladanyi M, Rodriguez M. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol. 2009;33(4):609–19.

    Article  PubMed  Google Scholar 

  36. Ross H, Argani P. Xp11 translocation renal cell carcinoma. Pathology. 2010;42(4):369–73.

    Article  CAS  PubMed  Google Scholar 

  37. Argani P, Lae M, Ballard E, Amin M, Manivel D, Hutchinson B, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006;24(10):1529–34.

    Article  CAS  PubMed  Google Scholar 

  38. Argani P, Antonescu C, Couturier J, Fournet J, Sciot R, Debiec-Rychter M, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t (X;1)(p11.2;q21). Am J Surg Pathol. 2002;26(12):1553–66.

    Article  PubMed  Google Scholar 

  39. Argani P, Antonescu C, Illei P, Lui M, Timmons C, Newbury R, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. Am J Pathol. 2001;159(1):179–92.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Suzigan S, Drut R, Faria P, Argani P, De Marzo A, Barbosa R, et al. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features. Int J Surg Pathol. 2007;15(2):199–203.

    Article  PubMed  Google Scholar 

  41. Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, et al. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am J Surg Pathol. 2013;37(6):804–15.

    Article  PubMed  Google Scholar 

  42. Argani P, Lal P, Hutchinson B, Lui M, Reuter V, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. Am J Surg Pathol. 2003;27(6):750–61.

    Article  PubMed  Google Scholar 

  43. Camparo P, Vasiliu V, Molinie B, Couturier J, Dykema K, Petillo D, et al. Renal translocation carcinomas: clinicopathology, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol. 2008;32(5):656–70.

    Article  PubMed  Google Scholar 

  44. Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, Martino M, et al. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation. Am J Clin Pathol. 2012;137:761–8.

    Article  PubMed  Google Scholar 

  45. Armah H, Parwani A. Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med. 2010;134:124–9.

    PubMed  Google Scholar 

  46. Argani P, Hicks J, De Marzo A, Albadine R, Illei P, Ladanyi M, et al. Xp11 translocation renal cell carcinoma: extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34(9):1295–303.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Martignoni G, Gobbo S, Camparo P, Brunelli M, Munari E, Segala D, et al. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol. 2011;24:1313–9.

    Article  CAS  PubMed  Google Scholar 

  48. Martignoni G, Pea M, Gobbo S, Brunelli M, Bonetti F, Segala D, et al. Cathepsin-K immunoreactivity distinguished MiTF-TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol. 2009;22:1016–22.

    Article  CAS  PubMed  Google Scholar 

  49. Geller J, Argani P, Adeniran A, Hampton D, De Marzo A, Hicks J, et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008;112(7):1607–16.

    Article  PubMed  Google Scholar 

  50. Rao Q, Guan B, Zhou X-J. Xp11.2 translocation renal cell carcinomas have a poorer prognosis than non-Xp11.2 translocation carcinomas in children and young adults: a meta-analysis. Int J Surg Pathol. 2010;18(6):458–64.

    Google Scholar 

  51. Geller J, Dome J. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2004;112:1607–16.

    Article  Google Scholar 

  52. Dal Cin P, Stas M, Sciot R, De Wever I, Van Damme B, Van den Berghe H. Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet. 1998;101:58–61.

    Article  CAS  PubMed  Google Scholar 

  53. Rais-Bahrami S, Drabick J, De Marzo A, Hicks J, Ho C, Caroe A, et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology. 2007;70(1):e3–6.

    Article  PubMed  Google Scholar 

  54. Ross H, Martignoni G, Argani P. Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med. 2012;136:391–9.

    Article  PubMed  Google Scholar 

  55. Chang I-W, Huang H-Y, Sung M-T. Melanotic Xp11 translocation renal cancer. Am J Surg Pathol. 2009;33:1894–901.

    Article  PubMed  Google Scholar 

  56. Varinot J, Camparo P, Beurtheret S, Barreda E, Comperat E. An adult case of melanotic Xp11 translocation renal cancers: distinct entity or sub-entity? Int J Surg Pathol. 2011;19:285–9.

    Article  PubMed  Google Scholar 

  57. Argani P, Lae M, Hutchinson B, Reuter V, Collins M, Perentesis J, et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surgical Pathol. 2005;29:230–40.

    Article  Google Scholar 

  58. Argani P, Yonescu R, Morsberger L, Morris K, Netto G, Smith N, et al. Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Pathol. 2012;36:1516–26.

    Article  Google Scholar 

  59. Argani P, Hawkins A, Griffin C, Goldstein J, Haas M, Beckwith B, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q21) chromosome translocation. Am J Pathol. 2001;158(6): 2089–96.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Petersson F, Vanecek T, Michal M, Martignoni G, Brunelli M, Halbhuber Z, et al. A distinctive translocation carcinoma of the kidney; “rosette forming,” t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. Hum Pathol. 2012;43:726–36.

    Article  CAS  PubMed  Google Scholar 

  61. Rao Q, Liu B, Cheng L, Zhu Y, Shi Q-l, Wu B, et al. Renal cell carcinomas with t(6;11)(p21;q12): a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEb gene fusion point, immunobiomarkers, and ultrastructural feature, as well as detection of the gene fusion by fluorescence in situ hybridization. Am J Surg Pathol. 2012;36(9):1327–38.

    Article  PubMed  Google Scholar 

  62. Jung SJ, Chung JI, Park SH, Ayala AG, Ro JY. Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis. Am J Surg Pathol. 2006;30(3):411–5.

    PubMed  Google Scholar 

  63. Amin MB, Gupta R, Ondrej H, McKenney JK, Michal M, Young AN, et al. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol. 2009;33(3):393–400.

    Article  PubMed  Google Scholar 

  64. Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol. 2011;42(1):146–50.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  65. Sterlacci W, Verdorfer I, Gabriel M, Mikuz G. Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic, and scintigraphic studies. Virchows Arch. 2008;452(1):91–5.

    Article  PubMed  Google Scholar 

  66. Alessandrini L, Fassan M, Gardiman MP, Guttilla A, Zattoni F, Galletti TP, et al. Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. Virchows Arch. 2012;461(3):345–50.

    Article  PubMed  Google Scholar 

  67. Abe K, Hasegawa T, Onodera S, Oishi Y, Suzuki M. Renal metastasis of thyroid carcinoma. Int J Urol. 2002;9(11):656–8.

    Article  PubMed  Google Scholar 

  68. Garcia-Sanchis L, Lopez-Aznar D, Oltra A, Rivas A, Alonso J, Montalar J, et al. Metastatic follicular thyroid carcinoma to the kidney: a case report. Clin Nucl Med. 1999;24(1):48–50.

    Article  CAS  PubMed  Google Scholar 

  69. Falzarano SM, Chute DJ, Magi-Galluzzi C. Metastatic papillary thyroid carcinoma to the kidney: report of two cases mimicking primary renal cell carcinoma and review of the literature. Pathology. 2013;45(1):89–93.

    Article  PubMed  Google Scholar 

  70. Shaco-Levy R, Bean SM, Bentley RC, Robboy SJ. Natural history of biologically malignant struma ovarii: analysis of 27 cases with extraovarian spread. Int J Gynecol Pathol. 2010;29(3):212–27.

    Article  PubMed  Google Scholar 

  71. Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol. 2009;28(5):405–22.

    Article  PubMed  Google Scholar 

  72. Ohe C, Kuroda N, Pan CC, Yang XJ, Hes O, Michal M, et al. A unique renal cell carcinoma with features of papillary renal cell carcinoma and thyroid-like carcinoma: a morphological, immunohistochemical and genetic study. Histopathology. 2010;57(3):494–497.

    Article  PubMed  Google Scholar 

  73. Fadare O, Lam S, Rubin C, Renshaw IL, Nerby CL. Papillary renal cell carcinoma with diffuse clear cells and thyroid-like macrofollicular areas. Ann Diagn Pathol. 2010;14(4):284–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Michigan Medical Center, Ann Arbor, MI, USA

    Asst. Prof. Angela Wu MD & Assoc. Prof. Lakshmi P. Kunju MD

  2. Department of Pathology, Cleveland Clinic, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland, OH, USA

    Asst. Prof. Christopher G. Przybycin MD

Authors
  1. Asst. Prof. Angela Wu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asst. Prof. Christopher G. Przybycin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Assoc. Prof. Lakshmi P. Kunju MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela Wu MD .

Editor information

Editors and Affiliations

  1. Department of Pathology, The Cleveland Clinic, Cleveland, Ohio, USA

    Cristina Magi-Galluzzi

  2. Department of Pathology, The Cleveland Clinic, Cleveland, Ohio, USA

    Christopher G. Przybycin

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wu, A., Przybycin, C., Kunju, L. (2015). Newly Described Entities in Renal Tumor Pathology. In: Magi-Galluzzi, C., Przybycin, C. (eds) Genitourinary Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2044-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2044-0_26

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2043-3

  • Online ISBN: 978-1-4939-2044-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation